Biliatresone: progress in biliary atresia study.

Area of Science:

• Hepatology
• Toxicology
• Pediatric Gastroenterology

Background:

• Biliary atresia (BA) is a leading cause of neonatal end-stage liver disease.
• Early diagnosis and treatment are crucial to prevent irreversible liver fibrosis within two months.
• The comprehensive etiology of BA remains largely unknown, with theories including viral infections, immune disorders, and genetic defects.

Purpose of the Study:

• To summarize recent research on biliatresone's role in biliary atresia (BA).
• To investigate whether biliatresone can offer insights into the etiology of human BA.
• To explore the involvement of glutathione (GSH) and heat shock protein 90 (HSP90) in BA pathogenesis.

Main Methods:

• Conducted a PubMed search using keywords: "biliary atresia", "biliatresone", "GSH", and "HSP90".
• Extracted relevant data from published articles and supplementary materials.
• Synthesized findings to propose a new pathogenic hypothesis for BA.

Main Results:

• Biliatresone demonstrated toxicity in animal models (zebrafish, mice).
• Pathogenic factors identified include glutathione (GSH), heat shock protein 90 (HSP90), and associated pathways.
• A hypothesis suggests BA occurrence may be linked to biliatresone or similar compounds from vegetables and altered intestinal flora.

Conclusions:

• Glutathione (GSH) and heat shock protein 90 (HSP90) are implicated in BA development.
• Maternal diet (high vegetable intake) and altered intestinal flora may contribute to BA, potentially explaining higher incidence in Asian populations.
• Further large-scale epidemiological research is required to validate these findings.